Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2008 1
2009 1
2016 1
2022 1
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Neurodevelopmental Outcomes From the PREVeNT Trial.
O'Kelley SE, Capal JK, McPherson TO, Patrick KE, Pearson DA, Davis PE, Currans K, Byars AW, Porter BE, Sahin M, Taub KS, Rajaraman R, Randle S, McClintock WM, Koenig MK, Frost MD, Werner K, Nolan DA, Wong M, Krefting JL, Cutter GR, Krueger DA, Bebin EM; PREVeNT Study Group. O'Kelley SE, et al. Among authors: mcclintock wm. Pediatr Neurol. 2025 Dec;173:88-97. doi: 10.1016/j.pediatrneurol.2025.09.006. Epub 2025 Sep 16. Pediatr Neurol. 2025. PMID: 41061327 Clinical Trial.
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.
Bebin EM, Peters JM, Porter BE, McPherson TO, O'Kelley S, Sahin M, Taub KS, Rajaraman R, Randle SC, McClintock WM, Koenig MK, Frost MD, Northrup HA, Werner K, Nolan DA, Wong M, Krefting JL, Biasini F, Peri K, Cutter G, Krueger DA; PREVeNT Study Group. Bebin EM, et al. Among authors: mcclintock wm. Ann Neurol. 2023 Aug 28:10.1002/ana.26778. doi: 10.1002/ana.26778. Online ahead of print. Ann Neurol. 2023. PMID: 37638552 Free PMC article.
Acoustic Injectors for Drop-On-Demand Serial Femtosecond Crystallography.
Roessler CG, Agarwal R, Allaire M, Alonso-Mori R, Andi B, Bachega JFR, Bommer M, Brewster AS, Browne MC, Chatterjee R, Cho E, Cohen AE, Cowan M, Datwani S, Davidson VL, Defever J, Eaton B, Ellson R, Feng Y, Ghislain LP, Glownia JM, Han G, Hattne J, Hellmich J, Héroux A, Ibrahim M, Kern J, Kuczewski A, Lemke HT, Liu P, Majlof L, McClintock WM, Myers S, Nelsen S, Olechno J, Orville AM, Sauter NK, Soares AS, Soltis SM, Song H, Stearns RG, Tran R, Tsai Y, Uervirojnangkoorn M, Wilmot CM, Yachandra V, Yano J, Yukl ET, Zhu D, Zouni A. Roessler CG, et al. Among authors: mcclintock wm. Structure. 2016 Apr 5;24(4):631-640. doi: 10.1016/j.str.2016.02.007. Epub 2016 Mar 17. Structure. 2016. PMID: 26996959 Free PMC article.
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.
Farach LS, Richard MA, Wulsin AC, Bebin EM, Krueger DA, Sahin M, Porter BE, McPherson TO, Peters JM, O'Kelley S, Taub KS, Rajaraman R, Randle SC, McClintock WM, Koenig MK, Frost MD, Werner K, Nolan DA, Wong M, Cutter G, Northrup H, Au KS; PREVeNT Study Group. Farach LS, et al. Among authors: mcclintock wm. Pediatr Neurol. 2024 Oct;159:62-71. doi: 10.1016/j.pediatrneurol.2024.06.012. Epub 2024 Jul 4. Pediatr Neurol. 2024. PMID: 39142021
Cerebral MRI abnormalities associated with vigabatrin therapy.
Pearl PL, Vezina LG, Saneto RP, McCarter R, Molloy-Wells E, Heffron A, Trzcinski S, McClintock WM, Conry JA, Elling NJ, Goodkin HP, de Menezes MS, Ferri R, Gilles E, Kadom N, Gaillard WD. Pearl PL, et al. Among authors: mcclintock wm. Epilepsia. 2009 Feb;50(2):184-94. doi: 10.1111/j.1528-1167.2008.01728.x. Epub 2008 Sep 8. Epilepsia. 2009. PMID: 18783433